9
POPSThe Genetic Early Adopters Knome is at the forefront of the push toward so-called personalized medicine. Scientists and physicians hope that when sequencing costs come down enough, genetic analysis will become a ubiquitous part of health care, helping doctors choose the best treatments for a specific patient, or helping individuals take steps to prevent diseases for which they are at risk.
15
POPSWhat Do Your Genes Say About You? The Future of Personal Genomics The company 23andMe announced its DNA testing service last month in San Diego. You might think such a comprehensive analysis would costs thousands, but the process is actually relatively affordable. For less than $1,000 customers are able to learn virtually everything science currently knows about their biological code. For those wary of needles, you’ll be comforted to know that the DNA is retrieved conveniently and painlessly from a home mail-in saliva test kit.
3
POPSWhat Do Your Genes Say About You? The Future of Personal Genomics Less than $1000 to have your genes checked. A maybe if you can face bad results. Just hope they don't become part of your work/insurance/medical insurance details required. And the lack of ethics in business would leave one wondering about the results cited by some insurance test.
1
POPSVaTech, D.O.E, Russians, collaborators study rare microorganism that produces hydrogen So we finally found a clean energy solution ? guess not - no2liberals writes "I’m all for new sources of energy, but one has to look at the downside. The only emission from hydrogen as a fuel is water vapor, which happens to be the single greatest greenhouse gas. Do we really want vehicles and power plants spewing more of the gas that traps 80% of all radiant heat within the first thirty feet of atmosphere?"
0
POPSMyriad Genetics Rebounds This speaks volumes about the way many investors felt about Myriad's Alzheimer's drug development program. The drug, Flurizan, failed yesterday. Shares dutifully fell. But today they ramped up to a level before the failure. This makes sense, because the drug development program was high risk, and was a drag on the company's genetic testing business. Now, investors can bet on a genomics and diagnostics company without worrying that a risky Alzheimer's drug is about to fail.
13
POPSWhen Unusually Rapid Improvement Becomes Usual Given the existing pressure on such social programs as Social Security and Medicare, I believe one implication of this “unusually rapid improvement” is that these systems will need to be radically overhauled in order to survive this new demographic reality.
0
POPSA Big Deal An Invitrogen-Applera combo could have a big impact, particularly in the genomics market.
0
POPSDNA Damage Checkpoint: Rad9 Include Human Rad9 gene preserves genomic integrity, plays multiple roles in fundamental, biological processes, indlucing the regulation of the DNA damage response.
8
POPSThe 100$ Genome Five years away, thats impressive. It means individualy tailored medicine within 10-15 years.
6
POPSSmoking and the smoking gene another report has drawn rather different conclusions... that genetic variation there acts directly on a person's susceptibility to lung cancer, rather than acting indirectly by modifying his smoking behaviour. That does not mean the gene or genes in question actually cause lung cancer. Rather, it means that they amplify the effects of smoking instead of the amount of smoking.
0
POPSIs Jim Watson Black? UPenn bioethicist Arthur Caplan weighs in on what it means to learn that a sixth of the DNA-discoverer's genes may have come from someone of African descent.
1
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update